At the news
? NEUTRALIMPACT 2/10 6-K filed Apr 16, 2026 at 09:38 ET
Dr. Reddy's Laboratories announced that its Board of Directors will consider recommending a final dividend for the fiscal year 2025-26. This is a routine disclosure ahead of an upcoming board meeting and contains no financial results or material changes to operations.
- Company: Dr. Reddy's Laboratories Ltd. (RDY)
- Filing Type: Form 6-K (foreign private issuer report)
- Event: Board meeting to consider final dividend for FY 2025-26
- Date of Filing: April 16, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access